Effect of diode laser as an adjunct to scaling and root planing in stage II garde B periodontitis with type 2 Diabetes

Effect of diode laser as an adjunct to scaling and root planing in stage II garde B periodontitis with type II Diabetes - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108247

Enrollment

Registered

2026-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K053- Chronic periodontitis

Interventions

Intervention1: Diode laser assisted scaling and root planing: Participants in the test group will receive conventional scaling and root planing followed by adjunctive diode laser irradiation. The diod

Eligibility

Inclusion criteria

Inclusion criteria: 1 Stage 2 Grade B periodontitis with Type 2 diabetes having at least two nonadjacent sites per quadrant with PPD of greater or equal to 5 mm and minimum 20 natural teeth 2 Adults aged between 35 to 60 years of both genders. 3.Patient who did not consume antibiotic in past 3 months, who have not undergone periodontal treatment in past 6 months. 4.Patients willing to participate and cooperate with study protocol. 5.Patients ready to give informed consent. 6.Patients ready to come for follow-up.

Exclusion criteria

Exclusion criteria: 1.Patient with the presence of proximal restoration, infrabony pocket, proximal and cervical caries, existence of rampant caries, dental malocclusion. 2.Pregnant or lactating mothers. 3.Patient on medications or smokers.

Design outcomes

Primary

Measure	Time frame
Effectiveness of Diode laser adjunct to scaling and root planing under parameters probing pocket depth from baseline to 60 days.Timepoint: baseline 1 day, 15 days, 30 days, and 60 days.	—

Secondary

Measure	Time frame
1. Change in Clinical Attachment Level (CAL) from baseline to 15, 30, and 60 days. 2. Change in Bleeding on Probing (BOP) at baseline, 15, 30, and 60 days. 3. Change in Plaque Index (PI) and Gingival Index (GI) at baseline, 15, 30, and 60 days. 4. Patient-reported pain/discomfort on Visual Analog Scale (VAS) at immediate, 15, 30, and 60 days.Timepoint: baseline 1 day, 15 days, 30 days, and 60 days.	—

Measure

Time frame

1. Change in Clinical Attachment Level (CAL) from baseline to 15, 30, and 60 days. 2. Change in Bleeding on Probing (BOP) at baseline, 15, 30, and 60 days. 3. Change in Plaque Index (PI) and Gingival Index (GI) at baseline, 15, 30, and 60 days. 4. Patient-reported pain/discomfort on Visual Analog Scale (VAS) at immediate, 15, 30, and 60 days.Timepoint: baseline 1 day, 15 days, 30 days, and 60 days.

—

Countries

India

Contacts

Public ContactDr Raju Anarthe

Pravara Instutute of Medical Sciences Loni

rajuanarthe@gmail.com93221159945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026